Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q2 FY26 results · Jul–Sep 2025
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,150.17 crore (up 1.3% from Q2 FY25) and net profit of ₹209.86 crore (down 1.0% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a standalone basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,150.17 | 1,135.16 | +1.3% | 937.03 | +22.7% |
| Other income | 9.90 | 8.50 | +16.5% | 7.69 | +28.7% |
| Total income | 1,160.07 | 1,143.66 | +1.4% | 944.72 | +22.8% |
| Profit before tax | 281.78 | 285.37 | −1.3% | 264.70 | +6.5% |
| Net profit for the period | 209.86 | 211.90 | −1.0% | 192.06 | +9.3% |
| EPS, basic (₹) | 64.65 | 65.28 | −1.0% | 59.17 | +9.3% |
| Net margin (%) | 18.2 | 18.7 | 20.5 |
Standalone
- Filed with BSE
- 06 Nov 2025, 22:23 IST
- Board meeting
- 06 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE